Description

Shandong Xinhua Pharmaceutical Company Limited, founded in Zibo, China in 1943, is a comprehensive enterprise dedicated to the research, development, manufacturing, and commercialization of a diverse range of pharmaceutical and chemical products. The company's operations are structured across key segments: bulk chemical drugs, finished pharmaceutical preparations, and chemical intermediates, alongside other associated businesses. Operating under its "Xinhua" brand, the company produces active pharmaceutical ingredients (APIs) and finished dosage forms for various therapeutic categories, including antipyretic analgesics, treatments for cardiovascular and cerebrovascular conditions, anti-infective agents, and medications targeting central nervous system disorders. Its extensive product catalog further includes traditional Chinese medicines, prepared herbal decoctions, antibiotics, biochemical drugs, anesthetics, antipsychotic medications, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, and controlled medical substances. In addition to pharmaceuticals, Shandong Xinhua manufactures chemical raw materials such as dimethyl sulfate, isobutylbenzene, 1,8-diazabicyclo, undec-7-ene, and tetramethylguanidine. The company also specializes in producing high-end steroid system APIs and their intermediates. Beyond its core manufacturing, the company provides a spectrum of services, including the design of medical projects, research and development of health products, and involvement in the import and export of goods and technologies. Its capabilities also extend to offering various dosage forms like powders for injection, tablets, hard capsules, granules, and dry suspensions. Ancillary business activities encompass certification services, electrical equipment engineering, installation and testing of chemical and electrical machinery, and the sale of mechanical, hardware, and electrical equipment. Furthermore, it delivers internet-based data, sales, and information services for the pharmaceutical and medical device industries. Shandong Xinhua Pharmaceutical Company Limited maintains a significant presence within the People's Republic of China and has expanded its reach internationally, serving markets across the Americas, Europe, and other global regions.